Search results

Found 150 pages
AUTHOR: PharmaTimes Reporter

Results per page

10 20 50 100

Sort by

Relevance Date

18 Mar 2015:

Cell Medica drug gets orphan status

Immunotherapy firm Cell Medica has been granted orphan drug status in the USA for its drug to treat rare lymphomas.  - News - PharmaTimes

by PharmaTimes Reporter

https://www.pharmatimes.com/news/cell_medica_drug_gets_orphan_status_971196

18 May 2017:

Bayer lymphoma candidate wins FDA priority review

Regulator backs copanlisib - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/bayer_lymphoma_candidate_wins_fda_priority_review_1193018

15 May 2017:

NHS cyber attack – fallout continues

Cancellations and slower health services after 48 NHS Trusts hit by ransomware - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/nhs_cyber_attack_fallout_continues_1192827

24 Mar 2017:

First Humira biosimilar approved in Europe

Amgen has won European approval for its first biosimilar, a version of AbbVie’s blockbuster Humira (adalimumab). - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/first_humira_biosimilar_approved_in_europe_1189962

15 May 2017:

Triple trial boost for Lilly's migraine drug

CGRP treatment galcanezumab looks to be course for regulatory submissions - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/triple_trial_boost_for_lillys_migraine_drug_1192845

27 May 2015:

Eight new medicines recommended by CHMP

Eight new medicines have been recommended for approval by the European Medicines Agency with three new cancer biologics also gaining the nod. - News - PharmaTimes

by PharmaTimes Reporter

https://www.pharmatimes.com/news/eight_new_medicines_recommended_by_chmp_971448

23 Jul 2014:

Zeltia looks at Aplidin combo for multiple myeloma

Zeltia has expanded the clinical programme for its investigational multiple myeloma treatment Aplidin. - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/zeltia_looks_at_aplidin_combo_for_multiple_myeloma_1002245

17 May 2017:

Sobi named UK's top haemophilia company

Tops IPC Associates' 2016 ranking - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/sobi_named_uks_top_haemophilia_company_1192985

17 May 2017:

FDA to fast-track Pfizer/Sangamo gene therapy orphan drug

SB-525 is being developed to treat haemophilia A - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/fda_to_fast-track_pfizersangamo_gene_therapy_orphan_drug_1192977

12 May 2017:

NHS Confederation calls on government for health funding plan

The body presents case for 10 'asks' before the snap election - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/nhs_confederation_calls_on_government_for_health_funding_plan_1192768